Bhaskaran A, Mumtaz K, Husain S. Anti-Aspergillus Prophylaxis in Lung Transplantation: A Systematic Review and Meta-analysis. Curr Infect Dis Rep 2013;15(6):514–25. https://www.ncbi.nlm.nih.gov/pubmed/24173585
Brizendine KD, Vishin S, Baddley JW. Antifungal prophylaxis in solid organ transplant recipients. Expert Rev Anti Infect Ther 2011;9(5):571–81. https://www.ncbi.nlm.nih.gov/pubmed/21609268
Fleming S, Yannakou CK, Haeusler GM, Clark J, Grigg A, Heath CH, et al. Consensus guidelines for antifungal prophylaxis in haematological malignancy and haemopoietic stem cell transplantation, 2014. Intern Med J 2014;44(12b):1283–97. https://www.ncbi.nlm.nih.gov/pubmed/25482741
Hicheri Y, Cook G, Cordonnier C. Antifungal prophylaxis in haematology patients: the role of voriconazole. Clin Microbiol Infect 2012;18 Suppl 2:1–15 .[PubMed]
Husain S, Sole A, Alexander BD, Aslam S, Avery R, Benden C, et al. The 2015 International Society for Heart and Lung Transplantation Guidelines for the management of fungal infections in mechanical circulatory support and cardiothoracic organ transplant recipients: Executive summary. J Heart Lung Transplant 2016;35(3):261–82. https://www.ncbi.nlm.nih.gov/pubmed/26970469
Jorgensen KJ, Gotzsche PC, Dalboge CS, Johansen HK. Voriconazole versus amphotericin B or fluconazole in cancer patients with neutropenia. Cochrane Database Syst Rev 2014;(2):CD004707. https://www.ncbi.nlm.nih.gov/pubmed/24563222
Maertens J, Marchetti O, Herbrecht R, Cornely OA, Fluckiger U, Frere P, et al. European guidelines for antifungal management in leukemia and hematopoietic stem cell transplant recipients: summary of the ECIL 3–2009 update. Bone Marrow Transplant 2011;46(5):709–18. https://www.ncbi.nlm.nih.gov/pubmed/20661235
Mellinghoff SC, Panse J, Alakel N, Behre G, Buchheidt D, Christopeit M, et al. Primary prophylaxis of invasive fungal infections in patients with haematological malignancies: 2017 update of the recommendations of the Infectious Diseases Working Party (AGIHO) of the German Society for Haematology and Medical Oncology (DGHO). Ann Hematol 2018;97(2):197–207. https://www.ncbi.nlm.nih.gov/pubmed/29218389
Neoh CF, Snell GI, Kotsimbos T, Levvey B, Morrissey CO, Slavin MA, et al. Antifungal prophylaxis in lung transplantation–a world-wide survey. Am J Transplant 2011;11(2):361–6. https://www.ncbi.nlm.nih.gov/pubmed/21272239
Pechlivanoglou P, Le HH, Daenen S, Snowden JA, Postma MJ. Mixed treatment comparison of prophylaxis against invasive fungal infections in neutropenic patients receiving therapy for haematological malignancies: a systematic review. J Antimicrob Chemother 2014;69(1):1–11. https://www.ncbi.nlm.nih.gov/pubmed/23975736
Slavin MA, Heath CH, Thursky KA, Morrissey CO, Szer J, Ling LM, et al. Antifungal prophylaxis in adult stem cell transplantation and haematological malignancy. Intern Med J 2008;38(6b):468–76. https://www.ncbi.nlm.nih.gov/pubmed/18588520
van Hal SJ, Marriott DJ, Chen SC, Nguyen Q, Sorrell TC, Ellis DH, et al. Candidemia following solid organ transplantation in the era of antifungal prophylaxis: the Australian experience. Transpl Infect Dis 2009;11(2):122–7. https://www.ncbi.nlm.nih.gov/pubmed/19220822
Wang JF, Xue Y, Zhu XB, Fan H. Efficacy and safety of echinocandins versus triazoles for the prophylaxis and treatment of fungal infections: a meta-analysis of RCTs. Eur J Clin Microbiol Infect Dis 2015;34(4):651–9. https://www.ncbi.nlm.nih.gov/pubmed/25502737
Ziakas PD, Kourbeti IS, Mylonakis E. Systemic antifungal prophylaxis after hematopoietic stem cell transplantation: a meta-analysis. Clin Ther 2014;36(2):292–306 e1. https://www.ncbi.nlm.nih.gov/pubmed/24439393
